5 min listen
SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens
SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens
ratings:
Length:
5 minutes
Released:
Mar 21, 2024
Format:
Podcast episode
Description
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.
Released:
Mar 21, 2024
Format:
Podcast episode
Titles in the series (99)
April 2, 2020 Issue Introduction by Neurology Today in 5